Karaya gum

Identification

Summary

Karaya gum is an extract from Karaya gum used in allergy testing.

Generic Name
Karaya gum
DrugBank Accession Number
DB10535
Background

Karaya gum allergenic extract is used in allergenic testing.

Type
Biotech
Groups
Approved
Biologic Classification
Allergenics
Allergen Extract
Synonyms
  • Gum karaya
  • Gum sterculia
  • Kadaya
  • Karaya
  • Karaya gum
  • Karaya gum allergenic extract
  • Karaya gum extract
  • Karaya resin
  • Katilo
  • Kullo
  • Kutterra
  • Sterculia
  • Sterculia gum
  • Sterculia resin
  • Sterculia urens resin
External IDs
  • E-416
  • Fema no. 2605
  • INS NO.416
  • INS-416

Pharmacology

Indication

Not Available

Pharmacology
Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Contraindications
Avoid life-threatening adverse drug events
Improve clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events & improve clinical decision support.
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Adverseeffects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.
Learn more
Improve decision support & research outcomes with our structured adverse effects data.
Learn more
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Products

Products2
Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now
Brand Name Prescription Products
NameDosageStrengthRouteLabellerMarketing StartMarketing EndRegionImage
Karaya GumSolution0.005 g/1mLIntradermal; Percutaneous; SubcutaneousGreer Laboratories, Inc.1981-09-15Not applicableUS flag
Karaya GumInjection, solution0.005 g/1mLIntradermal; SubcutaneousNelco Laboratories, Inc.1972-08-29Not applicableUS flag
Karaya GumInjection, solution0.005 g/1mLPercutaneousALK-Abello, Inc.1965-01-01Not applicableUS flag
Karaya GumSolution0.01 g/1mLIntradermal; Percutaneous; SubcutaneousGreer Laboratories, Inc.1981-09-15Not applicableUS flag
Karaya GumInjection, solution0.01 g/1mLIntradermal; SubcutaneousNelco Laboratories, Inc.1972-08-29Not applicableUS flag
Karaya GumSolution0.001 g/1mLIntradermal; Percutaneous; SubcutaneousGreer Laboratories, Inc.1981-09-15Not applicableUS flag
Karaya GumInjection0.01 g/1mLCutaneous; Intradermal; SubcutaneousAllermed Laboratories, Inc.1974-03-12Not applicableUS flag

Categories

ATC Codes
A06AC03 — SterculiaA06AC53 — Sterculia, combinations
Drug Categories
Classification
Not classified
Affected organisms
Not Available

Chemical Identifiers

UNII
73W9IQY50Q
CAS number
9000-36-6

References

General References
Not Available
PubChem Substance
347910695
RxNav
852617
Wikipedia
Karaya_gum

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
2Not Yet RecruitingTreatmentMalignant Melanoma of Skin1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
InjectionCutaneous; Intradermal; Subcutaneous0.01 g/1mL
Injection, solutionIntradermal; Subcutaneous0.005 g/1mL
Injection, solutionIntradermal; Subcutaneous0.01 g/1mL
Injection, solutionPercutaneous0.005 g/1mL
SolutionIntradermal; Percutaneous; Subcutaneous0.001 g/1mL
SolutionIntradermal; Percutaneous; Subcutaneous0.005 g/1mL
SolutionIntradermal; Percutaneous; Subcutaneous0.01 g/1mL
Granule
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available

Drug created on December 01, 2015 20:04 / Updated on June 12, 2020 16:53